Agilent to buy Proscia for $240M

T2Covered by 1 source · first reported by BioPharma Dive / Healthcare Dive / MedTech Dive at 14 Oct, 06:29 UTC

The digital pathology firm “fits in very well” with Agilent and moves the company into a sector targeted by Roche, analysts said.